USFDA completes pre-approval inspection at Biocon Malyasia

Image
Capital Market
Last Updated : Feb 21 2018 | 9:50 AM IST

Form 483 issued with 6 observations

Biocon announced that USFDA has completed a pre-approval inspection of its manufacturing facility in Malaysia and issued a Form 483 with 6 observations.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Feb 21 2018 | 9:22 AM IST

Next Story